Home › Prostate Cancer › NCT03354416

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Who can join

Ages 18 and older · Men

* INCLUSION CRITERIA:
* Patients with an increased risk for prostate cancer (strong family history and/or germline mutation in DNA repair genes), or with a diagnosis of prostatic cancer or suspicious for prostatic cancer lesions.
* Age greater than or equal to 18 years
* Ability of subject to understand and the willingness to sign a written informed consent document.

EXCLUSION CRITERIA:

-none

About the study

Background:

Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy. These could help manage prostate cancer. Researchers want to study how imaging can provide a profile of prostate cancer. They want to collect data to make diagnosis and treatments better.

Objectives:

To gather data about the radiological and clinical course of prostate cancer. To study imaging-based biomarkers of prostate cancer.

Eligibility:

Men ages 18 and older with diagnosed or suspected prostate cancer

Design:

Participants will give permission for researchers to use their medical history and records. Their data will be reviewed, collected, and analyzed. These include results of their tests and scans.

Sponsoring Institution: National Cancer Institute

Sponsor: National Cancer Institute (NCI) · Participants: 10,000 · Started: Feb 26, 2018

Contact the study team

• Yolanda L McKinney, R.N. · Phone: (240) 760-6095
• Ismail B Turkbey, M.D. · Phone: (240) 760-6112

Official record on ClinicalTrials.gov — NCT03354416

Locations in the U.S.

Conditions

• Prostate Cancer
• Enlarged Prostate (BPH)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.